Status:
ACTIVE_NOT_RECRUITING
Effects of Microencapsulated Propolis and Turmeric in Patients With Chronic Kidney Disease
Lead Sponsor:
Universidade Federal Fluminense
Conditions:
Chronic Kidney Diseases
Inflammation
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Oxidative stress and inflammation are correlated with Chronic Kidney Disease (CKD), in a way that they bring several harms to patients, including an increased risk of cardiovascular disease and mortal...
Detailed Description
The so-called Chronic Non-Communicable Diseases (NCDs) have been increasing in incidence. Among these, one can mention Chronic Kidney Disease (CKD). CKD is considered a public health problem and is ch...
Eligibility Criteria
Inclusion
- Patients with stage 5 CKD (GFR \< 15 mL/min);
- On hemodialysis for more than 6 months;
- Who have arteriovenous fistula (AVF) as vascular access
Exclusion
- Pregnant women;
- Smokers;
- Using antibiotics in the last 3 months;
- Using antioxidant supplements;
- Who have habitual intake of propolis, curcumin and turmeric;
- With autoimmune and infectious diseases, cancer, liver and AIDS (Acquired Immunodeficiency Syndrome)
Key Trial Info
Start Date :
March 7 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT05183737
Start Date
March 7 2022
End Date
December 31 2026
Last Update
April 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Denise Mafra
Rio de Janeiro, Rio de Janeiro, Brazil, 22260050